Treatment of short-bowel syndrome

Curr Opin Clin Nutr Metab Care. 2001 Nov;4(6):557-60. doi: 10.1097/00075197-200111000-00017.

Abstract

The present article reviews the current literature on the role of diet and other trophic factors in the treatment of short-bowel syndrome. Results using glutamine, growth hormone and glucagon-like peptide 2 are reviewed. Although experimental animal data would suggest that various growth factors are of benefit in the treatment of short-bowel syndrome, only a few clinical studies have made the same claim.

Publication types

  • Review

MeSH terms

  • Animals
  • Colon / physiology
  • Dietary Carbohydrates / administration & dosage
  • Dietary Carbohydrates / classification
  • Disease Models, Animal
  • Glucagon-Like Peptide 2
  • Glucagon-Like Peptides
  • Glutamine / therapeutic use
  • Growth Substances / therapeutic use
  • Humans
  • Intestine, Small / transplantation
  • Peptides / therapeutic use
  • Short Bowel Syndrome / diet therapy
  • Short Bowel Syndrome / surgery
  • Short Bowel Syndrome / therapy*

Substances

  • Dietary Carbohydrates
  • Glucagon-Like Peptide 2
  • Growth Substances
  • Peptides
  • Glutamine
  • Glucagon-Like Peptides